You are here

Approvals, Launches, and New Indications

Walnut-sized device uses spring-loaded microneedles
Treatment approved for post-HSCT maintenance in multiple myeloma patients
RNA-based test identifies biomarkers in whole blood
Siliq binds to pro-inflammatory protein
Inhalation spray now approved for age 6 and older
First U.S. approval of a corticosteroid for DMD
First new therapy for this indication in more than a decade
Only GLP-1 receptor agonist for use with mealtime insulin or basal insulin
Assay provides results within five to seven hours